Drug Type Autologous CAR-T |
Synonyms BCMA-PD1-CART Cells (Chinese People's Liberation Army General Hospital) |
Target |
Mechanism BCMA inhibitors(B-cell maturation protein inhibitors), PDL1 inhibitors(Programmed death-ligand 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plasma cell myeloma refractory | Phase 2 | CN | 07 Jul 2019 | |
Relapse multiple myeloma | Phase 2 | CN | 07 Jul 2019 |